Cargando…

Prostate-Specific Antigen Density: A Measurement to Differentiate Benign Hypertrophy of Prostate from Prostate Carcinoma

Background Determination of isolated prostate-specific antigen (PSA) in asymptomatic individuals has not demonstrated sufficient sensitivity and specificity to be useful in the routine evaluation of prostate disease. To enhance the accuracy of serum PSA we have used a proportion of serum PSA and pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nath, Chandan Kumar, Barman, Bhupen, Phukan, Pranjal, Sailo, Stephen L., Dey, Biswajit, Nath, Indrajit, Rajkhowa, Purnima
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Private Ltd. 2020
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419169/ https://www.ncbi.nlm.nih.gov/pubmed/32792793 http://dx.doi.org/10.1055/s-0040-1714195

Ejemplares similares

Clinical and Laboratory Presentation of Hydatid Disease: A Study From Northeast India
por: Baruah, Arup, et al.
Publicado: (2020)

Marijuana smoking: a possible cause of diffuse alveolar hemorrhage
por: Barman, Bhupen, et al.
Publicado: (2020)

Prolactin and thyroid stimulating hormone affecting the pattern of LH/FSH secretion in patients with polycystic ovary syndrome: A hospital-based study from North East India
por: Nath, Chandan K., et al.
Publicado: (2019)

Plasma neutrophil gelatinase-associated lipocalin (NGAL): A candidate biomarker to detect early acute kidney injury (AKI) for at-risk intensive care admissions
por: Nath, Chandan Kr, et al.
Publicado: (2022)

Doxazosin in the treatment of benign prostatic hypertrophy: an update
por: Wilt, Timothy J, et al.
Publicado: (2006)

Study of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency and Genotype Polymorphism of G6PD B and G6PD (A+/A-) in Patients Treated for Plasmodium vivax Malaria in a Tertiary Care Hospital in North East India
por: Rajkhowa, Purnima, et al.
Publicado: (2020)

Hemophagocytic Lymphohistiocytosis Secondary to Adult-Onset Still’s Disease
por: Barman, Bhupen, et al.
Publicado: (2021)

The differential presence of human polyomaviruses, JCPyV and BKPyV, in prostate cancer and benign prostate hypertrophy tissues
por: Shen, Chenghuang, et al.
Publicado: (2021)

Impact of Treatment With Statins on Prostate-Specific Antigen and Prostate Volume in Patients With Benign Prostatic Hyperplasia
por: Lee, Sang Hun, et al.
Publicado: (2013)

Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate Hyperplasia
por: Hsiao, Chun-Jen, et al.
Publicado: (2016)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
por: Putra, Ida Bagus O.W., et al.
Publicado: (2016)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
por: Merendino, Rosaria Alba, et al.
Publicado: (2003)

Update on the use of dutasteride in the management of benign prostatic hypertrophy
por: Miller, Joe, et al.
Publicado: (2007)

Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy
por: Yu, Simon Chun Ho, et al.
Publicado: (2016)

Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model
por: Natali, Pier Giorgio, et al.
Publicado: (2023)

Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
por: Kim, Jong Min, et al.
Publicado: (2011)

Prostate-Specific Antigen Mass and Free Prostate-Specific Antigen Mass for Predicting the Prostate Volume of Korean Men With Biopsy-Proven Benign Prostatic Hyperplasia
por: Park, Tae Yong, et al.
Publicado: (2013)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
por: Abotsi, Ebenezer, et al.
Publicado: (2022)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
por: Boo, Youngjun, et al.
Publicado: (2023)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
por: Shahab, Ahmad Anies, et al.
Publicado: (2013)

Prostatic Hypertrophy
por: Clinton, Marshall
Publicado: (1901)

Hypertrophy of the Prostate
por: McNeil, A.
Publicado: (1885)

Surgical therapy for benign prostatic hypertrophy/bladder outflow obstruction
por: Thiruchelvam, Nikesh
Publicado: (2014)

Evaluation of Molecular Species of Prostate-Specific Antigen Complexed with Immunoglobulin M in Prostate Cancer and Benign Prostatic Hyperplasia
por: Goč, Sanja, et al.
Publicado: (2013)

Secondary Hemophagocytic Lymphohistiocytosis in Post-COVID-19 Patients: A Report of Two Cases
por: Kalita, Pranjal, et al.
Publicado: (2021)

The Specific Choice of Transrectal Ultrasound-Guided Prostate Biopsy Scheme Based on Prostate Specific Antigen and Prostate Specific Antigen Density
por: Chen, Yue, et al.
Publicado: (2019)

Free Prostate-Specific Antigen Provides More Precise Data on Benign Prostate Volume Than Total Prostate-Specific Antigen in Korean Population
por: Choi, Hoon, et al.
Publicado: (2013)

Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions
por: Han, Liying, et al.
Publicado: (2022)

Correlation Between Prostate Volume Measured by Ultrasound and Detrusor Wall Thickness in Men with Benign Prostatic Hypertrophy
por: Ahuizechukwu, Obiesie Emmanuel, et al.
Publicado: (2020)

Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus
por: Sarwar, Shahana, et al.
Publicado: (2017)

Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
por: Xu, Bei, et al.
Publicado: (2021)

The use of prostate specific antigen density to predict clinically significant prostate cancer
por: Yusim, Igor, et al.
Publicado: (2020)

Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer
por: Zou, Bing-Zi, et al.
Publicado: (2023)

AB101. Diversity and choice in the surgical techniques for benign prostatic hypertrophy
por: He, Leye
Publicado: (2015)

In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy
por: Shah, Abhishek, et al.
Publicado: (2021)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Hypertrophy of the Prostate Gland
Publicado: (1891)

The Treatment of Prostatic Hypertrophy
por: Durand, C. Ferdinand
Publicado: (1898)

Prostatic Hypertrophy Treatment
por: Babler, E. A.
Publicado: (1906)

Cannot write session to /tmp/vufind_sessions/sess_rk12cekrtjr35aiikqs9urunmt